<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK493766" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK493766/" /><meta name="ncbi_pagename" content="KMT2B-Related Dystonia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>KMT2B-Related Dystonia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="KMT2B-Related Dystonia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/04/26" /><meta name="citation_author" content="Lucia Abela" /><meta name="citation_author" content="Manju Ann Kurian" /><meta name="citation_pmid" content="29697234" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK493766/" /><meta name="citation_keywords" content="DYT28" /><meta name="citation_keywords" content="DYT-KMT2B" /><meta name="citation_keywords" content="DYT-KMT2B" /><meta name="citation_keywords" content="DYT28" /><meta name="citation_keywords" content="Histone-lysine N-methyltransferase 2B" /><meta name="citation_keywords" content="KMT2B" /><meta name="citation_keywords" content="KMT2B-Related Dystonia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="KMT2B-Related Dystonia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Lucia Abela" /><meta name="DC.Contributor" content="Manju Ann Kurian" /><meta name="DC.Date" content="2018/04/26" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK493766/" /><meta name="description" content="KMT2B-related dystonia (DYT-KMT2B) is a complex childhood-onset (mean age 7 years) movement disorder described to date in 39 individuals. It is characterized by a progressive disease course evolving commonly from lower-limb focal dystonia into generalized dystonia with prominent cervical, cranial, and laryngeal involvement. Communication difficulties, secondary to articulation difficulties and low speech volume, are common. Bulbar dysfunction leads to impaired swallowing. Intellectual disability (ID) / developmental delay (DD) are commonly reported." /><meta name="og:title" content="KMT2B-Related Dystonia" /><meta name="og:type" content="book" /><meta name="og:description" content="KMT2B-related dystonia (DYT-KMT2B) is a complex childhood-onset (mean age 7 years) movement disorder described to date in 39 individuals. It is characterized by a progressive disease course evolving commonly from lower-limb focal dystonia into generalized dystonia with prominent cervical, cranial, and laryngeal involvement. Communication difficulties, secondary to articulation difficulties and low speech volume, are common. Bulbar dysfunction leads to impaired swallowing. Intellectual disability (ID) / developmental delay (DD) are commonly reported." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK493766/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/kmt2b-dystonia/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK493766/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B389FE041FAB100000000048F01AB.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK493766_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK493766_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kcnt1-epilepsy/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kabuki/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK493766_"><span class="title" itemprop="name"><i>KMT2B</i>-Related Dystonia</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: DYT28, DYT-KMT2B</div><p class="contrib-group"><span itemprop="author">Lucia Abela</span>, MD, MSc and <span itemprop="author">Manju Ann Kurian</span>, MA, MBBChir, PhD.</p><a data-jig="ncbitoggler" href="#__NBK493766_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK493766_ai__"><div class="contrib half_rhythm"><span itemprop="author">Lucia Abela</span>, MD, MSc<div class="affiliation small">Developmental Neurosciences Programme<br />UCL-Institute of Child Health<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@aleba.aicul" class="oemail">ku.ca.lcu@aleba.aicul</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Manju Ann Kurian</span>, MA, MBBChir, PhD<div class="affiliation small">Developmental Neurosciences Programme<br />UCL-Institute of Child Health<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@nairuk.ujnam" class="oemail">ku.ca.lcu@nairuk.ujnam</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 26, 2018</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="kmt2b-dystonia.Summary" itemprop="description"><h2 id="_kmt2b-dystonia_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>KMT2B</i>-related dystonia (DYT-<i>KMT2B</i>) is a complex childhood-onset (mean age 7 years) movement disorder described to date in 39 individuals. It is characterized by a progressive disease course evolving commonly from lower-limb focal dystonia into generalized dystonia with prominent cervical, cranial, and laryngeal involvement. Communication difficulties, secondary to articulation difficulties and low speech volume, are common. Bulbar dysfunction leads to impaired swallowing. Intellectual disability (ID) / developmental delay (DD) are commonly reported.</p><p>Additional findings can include eye movement abnormalities, skin changes, psychiatric comorbidities (attention-deficit/hyperactivity disorder, anxiety, depression, and obsessive-compulsive disorder), myoclonus, seizures, spasticity, and sensorineural hearing loss. Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals follow a similar disease course, though milder and atypical findings have been described.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of DYT-<i>KMT2B</i> is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with either a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KMT2B</i> or a heterozygous interstitial <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 19q13.12 that includes a <i>KMTB2</i> whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletion<i>.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i></p><ul><li class="half_rhythm"><div>Dystonia: Although pharmacologic treatment with levodopa and other commonly used anti-dystonic agents generally does not result in long-term benefit for the majority of patients, a trial of these agents is considered reasonable. One group observed a significant improvement of motor manifestations with an antimuscarinic (anticholinergic) agent. Bilateral globus pallidus interna deep brain stimulation results in substantial clinical improvement, particularly in younger patients.</div></li><li class="half_rhythm"><div>Other: Early initiation of physiotherapy and a tailored exercise program is advised as well as use of adaptive aids (e.g., ankle-foot orthoses, walkers) as necessary to support and maintain ambulation. Speech and language therapy is crucial to assist in feeding skills and communication. Nutrition specialists / dieticians are needed to assess calorie needs and reduce the risk of malnutrition. Address DD/ID issues through appropriate specialists/agencies.</div></li></ul><p><i>Surveillance:</i> Regular monitoring of weight and height in children, nutritional status, swallowing function, speech and language, adaptive functioning (ability to perform activities of daily living), orthopedic complications (hip dislocation and kyphoscoliosis), hearing, eye movements, skin, and psychiatric status.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>DYT-<i>KMT2B</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. To date, ~84% of individuals have the disorder as the result of a <i>de novo KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and ~16% have inherited the <i>KMT2B</i> variant (10% from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; 6% from a clinically asymptomatic parent). Each child of an individual with DYT-<i>KMT2B</i> has a 50% chance of inheriting the <i>KMT2B</i> pathogenic variant; reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and intrafamilial clinical variability have been reported. Once the <i>KMT2B</i> pathogenic variant has been identified in an affected family member, prenatal testing for an at-risk pregnancy and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="kmt2b-dystonia.Diagnosis"><h2 id="_kmt2b-dystonia_Diagnosis_">Diagnosis</h2><p>No formal diagnostic criteria for DYT-<i>KMT2B</i> have been published to date.</p><div id="kmt2b-dystonia.Suggestive_Findings"><h3>Suggestive Findings</h3><p>DYT-<i>KMT2B</i>
<b>should be suspected</b> in individuals with the following findings.</p><div id="kmt2b-dystonia.Clinical_Findings"><h4>Clinical Findings</h4><p>Typical disease course [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al 2016</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.lange.2017.1495">Lange et al 2017</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017a.1087">Zech et al 2017a</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017b.195">Zech et al 2017b</a>]:</p><ul><li class="half_rhythm"><div>Onset of dystonia usually within the first decade, but may be in the second decade or later</div></li><li class="half_rhythm"><div>Initial presentation:</div><ul><li class="half_rhythm"><div>In the majority, lower-limb dystonia (manifesting as toe-walking, abnormal gait, and balance difficulties)</div></li><li class="half_rhythm"><div>In some, upper-limb dystonia, and less commonly, cervical or truncal dystonia</div></li></ul></li><li class="half_rhythm"><div>With increasing age: prominent cervical, laryngeal, and/or cranial dystonia (manifesting as retrocollis, torticollis, dysarthria/anarthria, dysphonia, and difficulties in swallowing and chewing)</div></li><li class="half_rhythm"><div>Within two to 11 years of onset: evolution into generalized dystonia</div></li></ul></div><div id="kmt2b-dystonia.Neuroimaging"><h4>Neuroimaging</h4><p>Brain MRI abnormalities frequently reported in younger <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (age range: 3-18 years) include subtle and symmetric hypointense lateral streaks in the external globus pallidus (<a class="figpopup" href="/books/NBK493766/figure/kmt2b-dystonia.F1/?report=objectonly" target="object" rid-figpopup="figkmt2bdystoniaF1" rid-ob="figobkmt2bdystoniaF1">Figure 1</a>) on T<sub>2</sub>-weighted, T<sub>2</sub>*-weighted, susceptibility-weighted, and echo-planar b0-diffusion imaging data sets [<a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>].</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figkmt2bdystoniaF1" co-legend-rid="figlgndkmt2bdystoniaF1"><a href="/books/NBK493766/figure/kmt2b-dystonia.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figkmt2bdystoniaF1" rid-ob="figobkmt2bdystoniaF1"><img class="small-thumb" src="/books/NBK493766/bin/kmt2b-dystonia-Image001.gif" src-large="/books/NBK493766/bin/kmt2b-dystonia-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndkmt2bdystoniaF1"><h4 id="kmt2b-dystonia.F1"><a href="/books/NBK493766/figure/kmt2b-dystonia.F1/?report=objectonly" target="object" rid-ob="figobkmt2bdystoniaF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Radiologic MRI features of patients with <i>KMT2B</i> variants a-l. T<sub>2</sub>*-weighted (a, d) and T<sub>2</sub>-weighted (b, c) images; echo-planar technique diffusion imaging data set images with <i>b</i> value of zero (e-h); susceptibility-weighted sequences (i-l)</p></div></div><p>Note: This pattern may represent an age-dependent phenomenon as these features were often not evident in adults and may become less prominent over time. Indeed, in one individual such MR changes were less evident on MRI performed at age 17 years compared to neuroimaging performed at age 13 years.</p><p><b>DaTSCAN</b> and <b>FDG-PET-CT</b>
<b>scan</b> were normal in the three individuals evaluated with these methods.</p></div><div id="kmt2b-dystonia.Laboratory_Findings"><h4>Laboratory Findings</h4><p>CSF analysis in 13 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals showed the following minor perturbations of monoaminergic metabolites [<a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>]:</p><ul><li class="half_rhythm"><div>Marginal reduction of 5-hydroxyindoleacetic acid (5-HIAA) in three</div></li><li class="half_rhythm"><div>Mild elevation of 5-HIAA and tetrahydrobiopterin (BH4) in two others</div></li></ul></div></div><div id="kmt2b-dystonia.Establishing_the_Diagnosi"><h3>Establishing the Diagnosis</h3><p>The diagnosis of DYT-<i>KMT2B</i>
<b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with one of the following [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al 2016</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.lange.2017.1495">Lange et al 2017</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017a.1087">Zech et al 2017a</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017b.195">Zech et al 2017b</a>] (see <a class="figpopup" href="/books/NBK493766/table/kmt2b-dystonia.T.molecular_genetic_testi/?report=objectonly" target="object" rid-figpopup="figkmt2bdystoniaTmoleculargenetictesti" rid-ob="figobkmt2bdystoniaTmoleculargenetictesti">Table 1</a>):</p><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KMT2B</i> (26/36 probands reported to date)</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> interstitial <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 19q13.12 that encompasses the entirety of <i>KMTB2</i> (10/36 probands reported to date)</div></li></ul><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis, genomic sequencing, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Persons with the distinctive findings described in <a href="#kmt2b-dystonia.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing (see <a href="#kmt2b-dystonia.Option_1">Option 1</a>), whereas those in whom a specific diagnosis has been elusive are more likely to be diagnosed using comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (see <a href="#kmt2b-dystonia.Option_2">Option 2</a>).</p><div id="kmt2b-dystonia.Option_1"><h4>Option 1</h4><p>When the phenotypic and neuroimaging findings suggest the diagnosis of DYT-<i>KMT2B</i>, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis (CMA)</b> (if not already performed) followed by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing (<b>single-gene testing</b> or a dystonia <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>):</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>CMA</b> uses oligonucleotide or SNP arrays to detect genome-wide large deletions/duplications of 19q13.12 (including <i>KMT2B</i>) that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>KMT2B</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A dystonia</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>KMT2B</i> and other genes of interest (see <a href="#kmt2b-dystonia.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i> (3). In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK493766/table/kmt2b-dystonia.T.molecular_genetic_testi/?report=objectonly" target="object" rid-figpopup="figkmt2bdystoniaTmoleculargenetictesti" rid-ob="figobkmt2bdystoniaTmoleculargenetictesti">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="kmt2b-dystonia.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders with dystonia, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible. Exome array (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, particularly when evidence supports <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="kmt2b-dystonia.T.molecular_genetic_testi" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>KMT2B</i>-Related Dystonia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK493766/table/kmt2b-dystonia.T.molecular_genetic_testi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kmt2b-dystonia.T.molecular_genetic_testi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kmt2b-dystonia.T.molecular_genetic_testi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_kmt2b-dystonia.T.molecular_genetic_testi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_kmt2b-dystonia.T.molecular_genetic_testi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_kmt2b-dystonia.T.molecular_genetic_testi_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>KMT2B</i></td><td headers="hd_h_kmt2b-dystonia.T.molecular_genetic_testi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_kmt2b-dystonia.T.molecular_genetic_testi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">26/36&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.molecular_genetic_testi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_kmt2b-dystonia.T.molecular_genetic_testi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown (no data available)</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.molecular_genetic_testi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>7</sup></td><td headers="hd_h_kmt2b-dystonia.T.molecular_genetic_testi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10/36&#x000a0;<sup>4,&#x000a0;8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="kmt2b-dystonia.TF.1.1"><p class="no_margin">See <a href="/books/n/gene/kmt2b/#kmt2b.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="kmt2b-dystonia.TF.1.2"><p class="no_margin">See <a href="#kmt2b-dystonia.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="kmt2b-dystonia.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="kmt2b-dystonia.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="kmt2b-dystonia.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al [2016]</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.lange.2017.1495">Lange et al [2017]</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017a.1087">Zech et al [2017a]</a> (this paper includes two variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>), <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017b.195">Zech et al [2017b]</a></p></div></dd><dt>6. </dt><dd><div id="kmt2b-dystonia.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="kmt2b-dystonia.TF.1.7"><p class="no_margin">Chromosomal microarray analysis (CMA) using oligonucleotide arrays or SNP arrays identifies <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 19q13.12.</p></div></dd><dt>8. </dt><dd><div id="kmt2b-dystonia.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#kmt2b-dystonia.REF.dale.2012.618">Dale et al [2012]</a></p></div></dd></dl></div></div></div></div></div></div><div id="kmt2b-dystonia.Clinical_Characteristics"><h2 id="_kmt2b-dystonia_Clinical_Characteristics_">Clinical Characteristics</h2><p>Note: Except where indicated, information in this section is based on <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al [2016]</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.lange.2017.1495">Lange et al [2017]</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al [2017]</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017a.1087">Zech et al [2017a]</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017b.195">Zech et al [2017b]</a>, and <a class="bk_pop" href="#kmt2b-dystonia.REF.gorman.2018.245">Gorman et al [2018]</a>.</p><div id="kmt2b-dystonia.Clinical_Description"><h3>Clinical Description</h3><p><i>KMT2B</i>-related dystonia (DYT-<i>KMT2B</i>) is a complex childhood-onset movement disorder. It typically presents with a progressive disease course evolving commonly from lower-limb focal dystonia into generalized dystonia with prominent cervical, cranial, and laryngeal involvement. Additional neurologic, psychiatric, and systemic features are commonly reported. Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals follow a similar disease course, though milder and atypical cases have been described.</p><p>DYT-<i>KMT2B</i> has been recently described in 36 probands. Of these, one <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> had an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother and another had a similarly affected father and grandfather (total 39 individuals reported).</p><p>Disease onset typically occurs between ages one and 10 years (33/39 individuals); however, onset in the second decade was reported in five individuals for whom data were available. Mean age of onset was 7.05 years in 38 individuals for whom data were available.</p><p>Presenting manifestations (documented for 37/39 individuals) include the following:</p><ul><li class="half_rhythm"><div>Lower-limb dystonia characterized by foot posturing, toe walking, and gait disturbance (in 28 individuals)</div></li><li class="half_rhythm"><div>Upper-limb dystonia leading to abnormal hand/arm posturing, dystonic tremor, and difficulties in handwriting and hand dexterity (6)</div></li><li class="half_rhythm"><div>Cervical dystonia (1)</div></li><li class="half_rhythm"><div>Truncal/axial dystonia (1)</div></li><li class="half_rhythm"><div>Dystonic tremor and (action) myoclonus (1)</div></li></ul><p>Over time, the majority of individuals developed progressive cranial, cervical, and laryngeal dystonia with features of retrocollis, torticollis, dysarthria/anarthria, dysphonia, and difficulties in swallowing and chewing.</p><p>Affected individuals often have communication difficulties, secondary to articulation difficulties and low speech volume.</p><p>Bulbar dysfunction leads to impaired swallowing, which can cause substantial morbidity due to the risk of aspiration pneumonia. A few individuals with DYT-<i>KMT2B</i> have required gastrostomy insertion for feeding difficulties.</p><p>Generalized dystonia becomes evident in most individuals (34/39) within two to 11 years of initial presentation. The level of gross motor disability comprises a broad spectrum ranging from minor gait disturbance to wheelchair dependence (GMFCS II-V).</p><p>Developmental delay, described in 16 of 39 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, usually precedes the onset of dystonia and is thought to be non-progressive. Eight presented with neurodevelopmental delay, seven had <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> speech delay, and one had only delay in attainment of fine motor skills.</p><p>Mild cognitive impairment was reported in 21 of 39 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, most of whom developed variable degrees of functional independence in adolescence and adulthood.</p><p>Life expectancy is not known, but individuals in the seventh decade of life with DYT-<i>KMT2B</i> have been reported [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al 2016</a>].</p><p>Additional clinical features of DYT-<i>KMT2B</i> included the following (note that 9 individuals had &#x0003e;1 additional clinical feature):</p><ul><li class="half_rhythm"><div>Eye movement abnormalities including strabismus, astigmatism, delay in saccade initiation, hypometric vertical saccades, oculomotor apraxia (in 8 individuals)</div></li><li class="half_rhythm"><div>Dermatologic features of ectodermal dysplasia including cutis aplasia, sparse hair, sparse to absent eyelashes or brows, hypertrichosis, and ichthyotic skin with criss-cross pattern under the feet and at the knees (5). Although broad postsurgical scarring and "phimosis" have been reported, it is not currently known if these features are incidental or truly disease related. Future identification of further individuals with molecularly confirmed DYT-<i>KMT2B</i> may better clarify these associations.</div></li><li class="half_rhythm"><div>Psychiatric comorbidities including attention-deficit/hyperactivity disorder (ADHD), anxiety, depression, and obsessive-compulsive disorder (3)</div></li><li class="half_rhythm"><div>Myoclonus (3)</div></li><li class="half_rhythm"><div>Microcephaly (3)</div></li><li class="half_rhythm"><div>Seizures (2), including one with absence seizures</div></li><li class="half_rhythm"><div>Spasticity (1)</div></li><li class="half_rhythm"><div>Sensorineural hearing loss (1)</div></li><li class="half_rhythm"><div>Subtle <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features that may include an elongated face and bulbous nasal tip [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al 2016</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017a.1087">Zech et al 2017a</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017b.195">Zech et al 2017b</a>]</div></li></ul><p>The following atypical DYT-<i>KMT2B</i> disease manifestations [<a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>] are rarely reported:</p><ul><li class="half_rhythm"><div>Paroxysmal cervical dystonia, reported in one individual. Notably, the mother of this <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, who was found to harbor this <i>KMT2B</i> variant, had onset of symptoms in early adulthood. She developed gait abnormalities, a progressive inability to run, and periodic paroxysmal upper-limb and neck dystonia.</div></li><li class="half_rhythm"><div>Solely oromandibular features without clinical evidence of limb dystonia</div></li></ul></div><div id="kmt2b-dystonia.GenotypePhenotype_Correla"><h3>Genotype-Phenotype Correlations</h3><p><a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer and colleagues [2017]</a> reported statistically significant earlier disease onset in individuals with DYT-<i>KMT2B</i> with <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants (e.g., interstitial deletions; frameshift, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, and stop-gain variants) compared to those with <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. However, <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> does not appear to influence the rate of disease progression, disease severity, or clinical response to deep brain stimulation.</p><p>Early neurodevelopmental delay was reported in 5/10 individuals with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> 19q13.12 <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a>, compared to 11/29 with intragenic <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Likewise, the majority of individuals (8/10) with a heterozygous 19q13.12 contiguous gene deletion had mild cognitive impairment, compared to 13/29 with an intragenic <i>KMT2B</i> pathogenic variant. Identification of additional individuals with DYT-<i>KMT2B</i> will determine if this is a true <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation.</p></div><div id="kmt2b-dystonia.Penetrance"><h3>Penetrance</h3><p>DYT-<i>KMT2B</i> is postulated to show reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> as asymptomatic heterozygotes have been identified. Although parental status is not always known, to date two (6%) of 32 reported pathogenic variants have been inherited from a seemingly unaffected parent [<a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>].</p><p>Gender differences have not been observed to date.</p></div><div id="kmt2b-dystonia.Prevalence"><h3>Prevalence</h3><p>Disease prevalence is not yet established. To date, 39 individuals (from 36 families) with DYT-<i>KMT2B</i> have been described.</p></div></div><div id="kmt2b-dystonia.Genetically_Related_Allel"><h2 id="_kmt2b-dystonia_Genetically_Related_Allel_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>KMT2B</i>.</p></div><div id="kmt2b-dystonia.Differential_Diagnosis"><h2 id="_kmt2b-dystonia_Differential_Diagnosis_">Differential Diagnosis</h2><div id="kmt2b-dystonia.T.disorders_associated_wi" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders Associated with Complex Early-Onset Generalized Dystonia to Consider in the Differential Diagnosis of <i>KMT2B</i>-Related Dystonia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK493766/table/kmt2b-dystonia.T.disorders_associated_wi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kmt2b-dystonia.T.disorders_associated_wi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" style="text-align:left;vertical-align:middle;">Additional<br />Overlapping<br />Clinical<br />Features</th><th id="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5" colspan="3" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Distinguishing Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5" id="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical</th><th headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5" id="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MRI</th><th headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5" id="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Laboratory Findings</th></tr></thead><tbody><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" colspan="7" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Inherited forms of dystonia&#x000a0;<sup>1</sup></b></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/dystonia/">DYT-TOR1A</a> (DYT1)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TOR1A</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Isolated dystonia w/less prominent cervical/cranial/bulbar features early in disease course</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT-THAP1 (DYT6)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>THAP1</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early<br />craniofacial<br />involvement &#x00026;<br />laryngeal<br />dystonia</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Isolated dystonia w/older average age of onset</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DYT-PRKRA (DYT16)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRKRA</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild parkinsonism</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" colspan="7" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Early-onset NBIA disorders&#x000a0;<sup>2</sup></b></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pkan/">PKAN</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PANK2</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Parkinsonism</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Eye movement abnormalities</div></li><li class="half_rhythm"><div>Optic atrophy</div></li><li class="half_rhythm"><div>Axonal neuropathy</div></li><li class="half_rhythm"><div>Seizures</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;">Characteristic T<sub>2</sub>-weighted hypointensity in globus pallidus &#x00026; substantia nigra</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/inad/">PLAN</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLA2G6</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mt-mpan/">MPAN</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>C19orf12</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/bpan/">BPAN</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WDR45</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fahn/">FAHN</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FA2H</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Kufor-Rakeb syndrome</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP13A2</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CoPAN</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COASY</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" colspan="7" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Disorders of heavy metal metabolism</b></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wilson/">Wilson disease</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP7B</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Psychiatric<br />comorbidities</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Tremor</div></li><li class="half_rhythm"><div>Liver disease</div></li><li class="half_rhythm"><div>Kayser-Fleischer corneal ring</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Face-of-the-giant-panda sign</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02193; serum ceruloplasmin</div></li><li class="half_rhythm"><div>&#x02191; serum non-ceruloplasmin-bound copper</div></li></ul>
</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/slc39a14-def/">SLC39A14 deficiency</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC39A14</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Parkinsonism</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Bulbar dysfunction</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T<sub>1</sub>-weighted hyperintensities &#x00026; T<sub>2</sub>-weighted hypointensities in basal ganglia &#x00026; anterior pituitary gland, cerebellum, dorsal pons, spinal cord</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypermanganesemia</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hmdpc/">Dystonia/parkinsonism, hypermanganesemia, polycythemia, and chronic liver disease</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC30A10</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Parkinsonism</div></li><li class="half_rhythm"><div>Liver disease</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">T<sub>1</sub>-weighted hyperintensities in basal ganglia</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypermanganesemia</div></li><li class="half_rhythm"><div>Polycythemia</div></li></ul>
</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" colspan="7" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Neurotransmitter disorders</b></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/spr-def/">Sepiapterin reductase deficiency</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPR</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;">Hypotonia</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Progressive parkinsonism-dystonia</div></li><li class="half_rhythm"><div>Eye movement disorder</div></li><li class="half_rhythm"><div>Delayed motor milestones</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;">Reduced tracer uptake on DaTSCAN images (DTDS)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;">CSF neurotransmitter abnormalities</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GTPCH1 deficiency<br />(OMIM <a href="https://omim.org/entry/233910" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">233910</a>)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GCH1</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/thdrd/">Tyrosine hydroxylase deficiency</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TH</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Aromatic L-amino acid decarboxylase deficiency<br />(OMIM <a href="https://omim.org/entry/608643" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">608643</a>)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DDC</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brain serotonin-dopamine deficiency [<a class="bk_pop" href="#kmt2b-dystonia.REF.rilstone.2013.543">Rilstone et al 2013</a>]</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC18A2</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/slc6a3-dtds/"><i>SLC6A3</i>-related dopamine transporter deficiency syndrome</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC6A3</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" colspan="7" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Mitochondrial disorders</b></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/books/n/gene/mt-overview/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mitochondrial cytopathies</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR<br />Mat</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Multisystemic involvement</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Commonly shows "Leigh" radiologic appearance of T<sub>2</sub>-weighted hyperintensities in basal ganglia/brain stem/medulla</div></li><li class="half_rhythm"><div>Leukodystrophy</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02191; lactate, pyruvate</div></li><li class="half_rhythm"><div>Metabolic acidosis</div></li></ul>
</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/books/NBK26471/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><i>POLG</i>-related disorders</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLG</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" colspan="7" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Other inherited metabolic disorders</b></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Alpha-fucosidosis<br />(OMIM <a href="https://omim.org/entry/230000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">230000</a>)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FUCA1</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Dementia</div></li><li class="half_rhythm"><div>Delayed motor skills</div></li><li class="half_rhythm"><div>Dysostosis multiplex</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Angiokeratomas</div></li><li class="half_rhythm"><div>Distinct facial features</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Glutaric acidemia type 1<br />(OMIM <a href="http://omim.org/entry/231670" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">231670</a>)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GCDH</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Encephalopathic crisis associated w/infections/fever (between 6-18 mos)</div></li><li class="half_rhythm"><div>Macrocephaly</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Frontotemporal atrophy</div></li><li class="half_rhythm"><div>Widening of sylvian fissures</div></li><li class="half_rhythm"><div>T<sub>2</sub>-weighted hyperintensities in basal ganglia</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02191; urinary 3-OH-glutaric acid</div></li><li class="half_rhythm"><div>Glutaryl carnitine</div></li></ul>
</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Methylmalonic acidemia, late-onset (see <a href="/books/n/gene/mma/">Isolated Methylmalonic Acidemia</a>)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MCEE</i><br /><i>MMAA</i><br /><i>MMAB</i><br /><i>MMADHC</i><br /><i>MUT</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Hypotonia;<br />psychiatric<br />symptoms</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Failure to thrive</div></li><li class="half_rhythm"><div>Renal syndromes</div></li><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Metabolic stroke-like events</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02191; plasma &#x00026; urine MMA w/normal B<sub>12</sub>, tHcy, &#x00026; methionine levels</div></li><li class="half_rhythm"><div>&#x02191; propionylcarnitine (C3)</div></li><li class="half_rhythm"><div>Hyperammonemia</div></li><li class="half_rhythm"><div>Lactic acidosis</div></li></ul>
</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/propionic-a/">Propionic acidemia</a>, late-onset</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PCCA</i><br /><i>PCCB</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Failure to thrive</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Gastrointestinal symptoms</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>&#x02191; propionylcarnitine (C3) in plasma, &#x02191; 3-hydroxypropionate in urine, hyperammonemia, lactic acidosis</div></li></ul>
</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/npc/">Niemann-Pick&#x000a0;disease type C</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NPC1</i><br /><i>NPC2</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Hepatomegaly/</div><div>splenomegaly</div></li><li class="half_rhythm"><div>Supranuclear gaze palsy</div></li><li class="half_rhythm"><div>Cataplexy</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Psychiatric comorbidities</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; oxysterol levels</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GM1 gangliosidosis, type III<br />(see <a href="/books/n/gene/gm1-ganglio/"><i>GLB1</i>-Related Disorders</a>)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GLB1</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Extrapyramidal signs</div></li><li class="half_rhythm"><div>Skeletal abnormalities</div></li><li class="half_rhythm"><div>Cardiomyopathy</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lns/">Lesch-Nyhan&#x000a0;syndrome</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HPRT1</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pyramidal signs</div></li><li class="half_rhythm"><div>Self-mutilation</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hyperuricemia</td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" colspan="7" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Other monogenic disorders with prominent dystonia <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></b></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADCY5</i>-related movement disorder</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADCY5</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypotonia</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Chorea</div></li><li class="half_rhythm"><div>Orolingual dyskinesia</div></li><li class="half_rhythm"><div>Myoclonus</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Episodic exacerbations of movement disorder</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rapid-onset dystonia-parkinsonism (See <a href="/books/n/gene/rapid-odp/"><i>ATP1A3</i>-Related Neurologic Disorders</a>)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATP1A</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Parkinsonism</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Neuropsychiatric features</div></li><li class="half_rhythm"><div>Seizures</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193; tracer uptake on DaTSCAN images</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Juvenile-onset Parkinson disease<br />(see <a href="/books/n/gene/parkinson-overview/">Parkinson&#x000a0;Disease Overview</a>)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DNAJC6</i><br /><i>FBX07</i><br /><i>PARK7 (DJ1)</i><br /><i>PINK1</i><br /><i>PRKN (PARK2)</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Young-onset dystonia-parkinsonism (DYT16) [<a class="bk_pop" href="#kmt2b-dystonia.REF.camargos.2008.207">Camargos et al 2008</a>]</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRKRA</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/tubb4a-leuk/"><i>TUBB4A</i>-related leukodystrophy</a> (H-ABC)</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB4A</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>ID</div></li><li class="half_rhythm"><div>Motor delay</div></li><li class="half_rhythm"><div>Spasticity</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypomyelinating leukodystrophy</div></li><li class="half_rhythm"><div>Cerebellar &#x00026; basal ganglia atrophy</div></li></ul>
</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ddon/">Deafness-dystonia-optic neuronopathy syndrome</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TIMM8A</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pdc/">Pyruvate carboxylase deficiency</a></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PC</i></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_1_5 hd_h_kmt2b-dystonia.T.disorders_associated_wi_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; DD = developmental delay; ID = intellectual disability; Mat = maternal inheritance; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="kmt2b-dystonia.TF.2.1"><p class="no_margin">See <a href="/books/n/gene/dystonia-ov/">Hereditary Dystonia Overview</a>.</p></div></dd><dt>2. </dt><dd><div id="kmt2b-dystonia.TF.2.2"><p class="no_margin">See <a href="/books/n/gene/nbia-ov/">Neurodegeneration with Brain Iron Accumulation Disorders Overview</a>.</p></div></dd><dt>3. </dt><dd><div id="kmt2b-dystonia.TF.2.3"><p class="no_margin">Mitochondrial diseases are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. They can be caused by mutation of genes encoded by either nuclear DNA or mitochondrial DNA.</p></div></dd></dl></div></div></div></div><div id="kmt2b-dystonia.Management"><h2 id="_kmt2b-dystonia_Management_">Management</h2><div id="kmt2b-dystonia.Evaluations_Following_Ini"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with DYT-<i>KMT2B</i>, the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Complete detailed neurologic examination to delineate movement disorder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (dystonia, myoclonus, spasticity)</div></li><li class="half_rhythm"><div>Consider early assessment for possible effectiveness of deep brain stimulation</div></li><li class="half_rhythm"><div>Physiotherapy, occupational therapy, and speech and language therapy assessment</div></li><li class="half_rhythm"><div>Evaluation of swallowing safety (videofluoroscopy may be needed)</div></li><li class="half_rhythm"><div>Nutritional evaluation to ensure adequate calorie intake</div></li><li class="half_rhythm"><div>Developmental assessment / IQ testing</div></li><li class="half_rhythm"><div>Orthopedic examination for secondary complications including fixed contractures, joint dislocation, and/or kyphoscoliosis</div></li><li class="half_rhythm"><div>Ophthalmologic examination including assessment of vision and eye movements</div></li><li class="half_rhythm"><div>Assessment of hearing</div></li><li class="half_rhythm"><div>Formal neuropsychiatric testing</div></li><li class="half_rhythm"><div>Dermatologic examination</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="kmt2b-dystonia.Treatment_of_Manifestatio"><h3>Treatment of Manifestations</h3><p><b>Dystonia.</b> Although pharmacologic treatment with levodopa and other commonly used anti-dystonic agents (e.g., trihexiphenidyl, baclofen, gabapentin, tetrabenazine, benzodiazepines) has not proven to result in long-term benefit for the majority of patients with DYT-<i>KMT2B</i> [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al 2016</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017a.1087">Zech et al 2017a</a>], a trial of these anti-dystonia agents would be considered reasonable. <a class="bk_pop" href="#kmt2b-dystonia.REF.lange.2017.1495">Lange and colleagues [2017]</a> observed a significant improvement of motor manifestations on treatment with an antimuscarinic (anticholinergic) agent.</p><p>Bilateral globus pallidus interna deep brain stimulation (DBS) results in substantial clinical improvement, particularly in younger patients, and should be considered as a possible therapeutic route for patients with DYT-<i>KMT2B</i> based on the following results [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al 2016</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017a.1087">Zech et al 2017a</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017b.195">Zech et al 2017b</a>]:</p><ul><li class="half_rhythm"><div>Three patients regained independent ambulation.</div></li><li class="half_rhythm"><div>Five patients demonstrated sustained clinical effect at eight years following implantation.</div></li></ul><p>Early initiation of physiotherapy and a tailored exercise program is essential to maintain function and prevent secondary orthopedic complications such as joint contractures, hip dislocation, and/or kyphoscoliosis.</p><p>Adaptive aids (e.g., ankle-foot orthoses, walkers) should be supplied to support and maintain ambulation.</p><p><b>Speech and language therapy</b> is crucial to assist in feeding skills and communication. Some patients may need communication devices.</p><p><b>Nutrition specialists / dieticians</b> are of utmost importance to assess calorie needs and reduce the risk of malnutrition.</p><p>Videofluoroscopy can be used to evaluate the risk of aspiration and assess the need for alternative means of feeding.</p><p>For patients with respiratory compromise from chest deformities related to scoliosis, prophylactic antibiotics during the winter months, regular physiotherapy, and influenza immunizations should be considered due to the increased risk of pulmonary infections.</p><div id="kmt2b-dystonia.Developmental_Delay__Inte"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="kmt2b-dystonia.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility.</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy, typically from an occupational or speech therapist, is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="kmt2b-dystonia.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions such as applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications (e.g., medication used to treat ADHD) when necessary.</p></div></div><div id="kmt2b-dystonia.Surveillance"><h3>Surveillance</h3><p>Surveillance includes regular monitoring of the following:</p><ul><li class="half_rhythm"><div>Weight and height using age-appropriate and gender-matched growth charts in children</div></li><li class="half_rhythm"><div>Nutritional status to evaluate dietary requirements</div></li><li class="half_rhythm"><div>Swallowing to evaluate risk for aspiration</div></li><li class="half_rhythm"><div>Speech and language regarding needs for augmentative communication</div></li><li class="half_rhythm"><div>Adaptive functioning (ability to perform activities of daily living)</div></li><li class="half_rhythm"><div>Potential orthopedic complications (e.g., hip dislocation and kyphoscoliosis with hip and spine x-rays every 6 to 12 months)</div></li><li class="half_rhythm"><div>Hearing</div></li><li class="half_rhythm"><div>Strabismus and refractive errors</div></li><li class="half_rhythm"><div>Skin examination for changes requiring appropriate management</div></li><li class="half_rhythm"><div>Psychiatric status</div></li></ul></div><div id="kmt2b-dystonia.Evaluation_of_Relatives_a"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#kmt2b-dystonia.Related_Genetic_Counselin">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="kmt2b-dystonia.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Before conception, counseling on the potential effects of antidystonic medications on the pregnancy and developing fetus should be discussed and an appropriate plan on managing medications during pregnancy should be established. Pregnant women with DYT-<i>KMT2B</i> should also be advised about the induction of dystonic side effects of antiemetics [<a class="bk_pop" href="#kmt2b-dystonia.REF.nageshwaran.2011">Nageshwaran et al 2011</a>].</p><p>Data on the use of antidystonic agents in pregnancy are scarce. Although single case reports of medical treatment with trixhexyphenidyl, levodopa/carbidopa, and clonazepam during pregnancy have not observed adverse effects on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother or the fetus [<a class="bk_pop" href="#kmt2b-dystonia.REF.watanabe.2009.562">Watanabe et al 2009</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.mendhekar.2011.83">Mendhekar &#x00026; Andrade 2011</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.nageshwaran.2011">Nageshwaran et al 2011</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.robottom.2011.340">Robottom &#x00026; Reich 2011</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.serikawa.2011.72">Serikawa et al 2011</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.watanabe.2012.559">Watanabe &#x00026; Matsubara 2012</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.dostal.2013.1241">Dostal et al 2013</a>], oral medications may be preferably tapered to the lowest effective dose.</p><p>Treatment with DBS has been reported in a series of cases with implantation prior to conception [<a class="bk_pop" href="#kmt2b-dystonia.REF.scelzo.2015.191">Scelzo et al 2015</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.ziman.2016.60">Ziman et al 2016</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.park.2017.155">Park et al 2017</a>]. No adverse effects on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother and the fetus have been reported to date.</p><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="kmt2b-dystonia.Therapies_Under_Investiga"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="kmt2b-dystonia.Genetic_Counseling"><h2 id="_kmt2b-dystonia_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="kmt2b-dystonia.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>KMT2B</i>-related dystonia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="kmt2b-dystonia.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>When parental DNA was available (32/39), ~84% of individuals diagnosed with DYT-<i>KMT2B</i> had the disorder as the result of a <i>de novo KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al 2016</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.lange.2017.1495">Lange et al 2017</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017a.1087">Zech et al 2017a</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017b.195">Zech et al 2017b</a>].</div></li><li class="half_rhythm"><div>Approximately 16% of individuals diagnosed with DYT-<i>KMT2B</i> inherited a <i>KMT2B</i> variant: 10% from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent and 6% from a clinically asymptomatic parent (see <a href="#kmt2b-dystonia.Penetrance">Penetrance</a>) [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al 2016</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>]. Clinical variability within families is reported.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with DYT-<i>KMT2B</i> may appear to be negative because of failure to recognize the disorder in family members, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have somatic (and <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>) <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to sibs of inheriting the pathogenic variant is 50%, intrafamilial clinical variability and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> have been observed in DYT-<i>KMT2B</i>.</div></li><li class="half_rhythm"><div>If the <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the estimated <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#kmt2b-dystonia.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If both parents are clinically unaffected but have not been tested for the <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are still at increased risk for DYT-<i>KMT2B</i> because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with DYT-<i>KMT2B</i> has a 50% chance of inheriting the <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and intrafamilial clinical variability have been reported [<a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al 2016</a>].</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="kmt2b-dystonia.Related_Genetic_Counselin"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="kmt2b-dystonia.Prenatal_Testing_and_Prei"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="kmt2b-dystonia.Resources"><h2 id="_kmt2b-dystonia_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Dystonia Coalition</b></div><div><i>The Dystonia Coalition is a collaboration of medical researchers and patient advocacy groups that is working to advance the pace of clinical and translational research in the dystonias to find better treatments.</i></div><div><a href="http://www.rarediseasesnetwork.org/cms/dystonia/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rarediseasesnetwork.org/cms/dystonia</a></div></li><li class="half_rhythm"><div><b>Dystonia Medical Research Foundation</b></div><div>One East Wacker Drive</div><div>Suite 1730</div><div>Chicago IL 60601-1905</div><div><b>Phone:</b> 800-377-3978 (toll-free); 312-755-0198</div><div><b>Fax:</b> 312-803-0138</div><div><b>Email:</b> dystonia@dystonia-foundation.org</div><div><a href="http://www.dystonia-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia-foundation.org</a></div></li><li class="half_rhythm"><div><b>Dystonia Society</b></div><div>89 Albert Embankment</div><div>3rd Floor</div><div>London SE1 7TP</div><div>United Kingdom</div><div><b>Phone:</b> 0845 458 6211; 0845 458 6322 (Helpline)</div><div><b>Fax:</b> 0845 458 6311</div><div><b>Email:</b> support@dystonia.org.uk</div><div><a href="http://www.dystonia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia.org.uk</a></div></li><li class="half_rhythm"><div><b>German Dystonia Network and Registry</b></div><div>Germany</div><div><a href="http://www.research4rare.de/en/research_networks/dystract-3/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.research4rare.de</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/dystonia.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dystonia</a></div></li><li class="half_rhythm"><div><b>Dystonia Europe</b></div><div>Square de Meeus 37</div><div>4th Floor</div><div> Brussels Hoofdstedelijk Gewest 1000</div><div>Belgium</div><div><b>Phone:</b> 46 739 98 49 61</div><div><b>Email:</b> sec@dystonia-europe.org</div><div><a href="https://dystonia-europe.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.dystonia-europe.org</a></div></li><li class="half_rhythm"><div><b>Global Dystonia Registry</b></div><div><a href="http://www.globaldystoniaregistry.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.globaldystoniaregistry.org</a></div></li></ul></div><div id="kmt2b-dystonia.Molecular_Genetics"><h2 id="_kmt2b-dystonia_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="kmt2b-dystonia.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>KMT2B-Related Dystonia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK493766/table/kmt2b-dystonia.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kmt2b-dystonia.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_kmt2b-dystonia.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_kmt2b-dystonia.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_kmt2b-dystonia.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_kmt2b-dystonia.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_kmt2b-dystonia.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_kmt2b-dystonia.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9757" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KMT2B</i></a></td><td headers="hd_b_kmt2b-dystonia.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9757" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19q13<wbr style="display:inline-block"></wbr>​.12</a></td><td headers="hd_b_kmt2b-dystonia.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UMN6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Histone-lysine N-methyltransferase 2B</a></td><td headers="hd_b_kmt2b-dystonia.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KMT2B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KMT2B</a></td><td headers="hd_b_kmt2b-dystonia.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KMT2B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KMT2B</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="kmt2b-dystonia.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="kmt2b-dystonia.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for KMT2B-Related Dystonia (<a href="/omim/606834,617284" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK493766/table/kmt2b-dystonia.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kmt2b-dystonia.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606834" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606834</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LYSINE-SPECIFIC METHYLTRANSFERASE 2B; KMT2B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/617284" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">617284</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DYSTONIA 28, CHILDHOOD-ONSET; DYT28</td></tr></tbody></table></div></div><div id="kmt2b-dystonia.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>KMT2B</i> encodes a ubiquitously expressed lysine-specific histone methyl-transferase. Histone <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> represents a post-translational epigenetic mechanism to either repress or activate <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> transcription in a residue-specific manner [<a class="bk_pop" href="#kmt2b-dystonia.REF.shi.2007.1">Shi &#x00026; Whetstine 2007</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.shilatifard.2008.341">Shilatifard 2008</a>]. KMT2B is a member of the SET/MLL protein family that is specifically involved in histone 3 lysine 4 (H3K4) methylation. H3K4 is enriched at promoter, enhancer, and other regulatory sequences and associated with active transcription [<a class="bk_pop" href="#kmt2b-dystonia.REF.barski.2007.823">Barski et al 2007</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zhou.2011.7">Zhou et al 2011</a>]. Besides gene activation, H3K4 is also thought to be essential for transcriptional stability and enhanced transcriptional consistency [<a class="bk_pop" href="#kmt2b-dystonia.REF.muramoto.2010.397">Muramoto et al 2010</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.benayoun.2014.673">Benayoun et al 2014</a>].</p><p>The exact pathogenic mechanisms in DYT-<i>KMT2B</i> still remain to be fully elucidated. Given that dysregulated H3K4 <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> has an effect on the transcriptional activation and stability of a variety of genes, it is likely that additional genes or other genetic mechanisms contribute to DYT-<i>KMT2B</i>.</p><p>Several patients harbor small deletions on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 19q.13.12, a region that encompasses <i>KMT2B.</i> It is possible that other genes within these <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> deletions could additionally contribute to the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p><b>Gene structure.</b> The protein coding transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_014727.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014727.2</a> encompasses 37 exons.</p><p><b>Pathogenic variants.</b>
<i>KMT2B</i> variants have been identified in 39 individuals with early-onset complex dystonia [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2016.1377">Zech et al 2016</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>]. In addition to frameshift, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, small overlapping interstitial deletions of <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 19q13.12 have also been detected. For the ten individuals with reported small deletions, the smallest region of overlap spanned from 36,191,000 bp to 36,229,548 bp, encompassing two genes, <i>ZBTB32</i> and <i>KMT2B</i> (<i>MLL4</i>). Given that a number of <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> pathogenic variants are reported in DYT-<i>KMT2B</i>, it is likely that pathogenic variants result in <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>.</p><p>Novel <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been reported recently in another four unrelated individuals [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017a.1087">Zech et al 2017a</a>, <a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017b.195">Zech et al 2017b</a>]:</p><ul><li class="half_rhythm"><div>Two variants are of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> due to unknown parental inheritance.</div></li><li class="half_rhythm"><div>Two variants showed strong conservation and were predicted to be likely protein damaging [<a class="bk_pop" href="#kmt2b-dystonia.REF.zech.2017a.1087">Zech et al 2017a</a>]:</div><ul><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK493766/table/kmt2b-dystonia.T.pathogenic_kmt2b_varian/?report=objectonly" target="object" rid-figpopup="figkmt2bdystoniaTpathogenickmt2bvarian" rid-ob="figobkmt2bdystoniaTpathogenickmt2bvarian">p.Ala1541Val</a> was transmitted to two unaffected adult offspring.</div></li><li class="half_rhythm"><div><a class="figpopup" href="/books/NBK493766/table/kmt2b-dystonia.T.pathogenic_kmt2b_varian/?report=objectonly" target="object" rid-figpopup="figkmt2bdystoniaTpathogenickmt2bvarian" rid-ob="figobkmt2bdystoniaTpathogenickmt2bvarian">p.Arg1779Gln</a> was present in an individual in the ExAC population database.</div></li></ul></li></ul><p><a class="bk_pop" href="#kmt2b-dystonia.REF.lange.2017.1495">Lange et al [2017]</a> identified a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with early-onset dystonia with a novel three-bp <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> that affects a highly conserved amino acid located within the PHD-like <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> that is important for DNA-protein and protein-protein interaction. Protein modeling revealed altered loop formation and impaired coordination of a zinc ion.</p><div id="kmt2b-dystonia.T.pathogenic_kmt2b_varian" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Pathogenic <i>KMT2B</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK493766/table/kmt2b-dystonia.T.pathogenic_kmt2b_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__kmt2b-dystonia.T.pathogenic_kmt2b_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_kmt2b-dystonia.T.pathogenic_kmt2b_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_kmt2b-dystonia.T.pathogenic_kmt2b_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_kmt2b-dystonia.T.pathogenic_kmt2b_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_kmt2b-dystonia.T.pathogenic_kmt2b_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4622C&#x0003e;T</td><td headers="hd_h_kmt2b-dystonia.T.pathogenic_kmt2b_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala1541Val</td><td headers="hd_h_kmt2b-dystonia.T.pathogenic_kmt2b_varian_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_014727.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_014727<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_055542.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_055542<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_kmt2b-dystonia.T.pathogenic_kmt2b_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.5336G&#x0003e;A</td><td headers="hd_h_kmt2b-dystonia.T.pathogenic_kmt2b_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1779Gln</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>KMT2B</i> has a single protein-coding transcript of 8,469 bp. The protein encompasses 2,715 amino acids and consists of multiple functional domains including a CXXC zinc finger, three PHD/PHD-like zinc fingers domains, two FY-rich domains, and a C-terminal SET (<i>s</i>uppressor of variegation, <i>e</i>nhancer of zeste, and <i>t</i>rithorax) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (RefSeq, Jul 2008). The KMT2B protein belongs to the MLL (mixed-lineage leukemia) protein family, which is characterized by a conserved C-terminal catalytic SET domain. KMT2B is ubiquitously expressed in the brain with highest expression in the cerebellum [<a class="bk_pop" href="#kmt2b-dystonia.REF.meyer.2017.223">Meyer et al 2017</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Loss-of-function <i>KMT2B</i> pathogenic variants are predicted to alter gene dosage, leading to <i>KMT2B</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>. The effect of <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants remains to be fully elucidated, but they may affect normal protein stability and function. Abnormal KMT2B protein function may lead to dysregulated gene expression.</p><p>The role of <i>KMT2B</i> has been investigated using a mouse model [<a class="bk_pop" href="#kmt2b-dystonia.REF.kerimoglu.2013.3452">Kerimoglu et al 2013</a>]. A conditional knockdown of <i>KMT2B</i> in forebrain excitatory neurons resulted in downregulation of a specific subset of genes. The mouse model had evidence of impaired memory formation but no dystonia.</p></div></div><div id="kmt2b-dystonia.References"><h2 id="_kmt2b-dystonia_References_">References</h2><div id="kmt2b-dystonia.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.barski.2007.823">Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. <span><span class="ref-journal">Cell. </span>2007;<span class="ref-vol">129</span>:823–37.</span> [<a href="/pubmed/17512414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17512414</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.benayoun.2014.673">Benayoun BA, Pollina EA, Ucar D, Mahmoudi S, Karra K, Wong ED, Devarajan K, Daugherty AC, Kundaje AB, Mancini E, Hitz BC, Gupta R, Rando TA, Baker JC, Snyder MP, Cherry JM, Brunet A. H3K4me3 breadth is linked to cell identity and transcriptional consistency. <span><span class="ref-journal">Cell. </span>2014;<span class="ref-vol">158</span>:673–88.</span> [<a href="/pmc/articles/PMC4137894/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4137894</span></a>] [<a href="/pubmed/25083876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25083876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.camargos.2008.207">Camargos S, Scholz S, Sim&#x000f3;n-S&#x000e1;nchez J, Pais&#x000e1;n-Ruiz C, Lewis P, Hernandez D, Ding J, Gibbs JR, Cookson MR, Bras J, Guerreiro R, Oliveira CR, Lees A, Hardy J, Cardoso F, Singleton AB. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. <span><span class="ref-journal">Lancet Neurol. </span>2008;<span class="ref-vol">7</span>:207–15.</span> [<a href="/pubmed/18243799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18243799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.dale.2012.618">Dale RC, Grattan-Smith P, Nicholson M, Peters GB. Microdeletions detected using chromosome microarray in children with suspected genetic movement disorders: a single-centre study. <span><span class="ref-journal">Dev Med Child Neurol. </span>2012;<span class="ref-vol">54</span>:618–23.</span> [<a href="/pubmed/22515636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22515636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.dostal.2013.1241">Dostal M, Weber-Schoendorfer C, Sobesky J, Schaefer C. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series. <span><span class="ref-journal">Eur J Neurol. </span>2013;<span class="ref-vol">20</span>:1241–6.</span> [<a href="/pubmed/23083216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23083216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.gorman.2018.245">Gorman KM, Meyer E, Kurian MA. Review of the phenotype of early-onset generalised progressive dystonia due to mutations in KMT2B. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2018;<span class="ref-vol">22</span>:245–56.</span> [<a href="/pubmed/29289525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29289525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.kerimoglu.2013.3452">Kerimoglu C, Agis-Balboa RC, Kranz A, Stilling R, Bahari-Javan S, Benito-Garagorri E, Halder R, Burkhardt S, Stewart AF, Fischer A. Histone-methyltransferase MLL2 (KMT2B) is required for memory formation in mice. <span><span class="ref-journal">J Neurosci. </span>2013;<span class="ref-vol">33</span>:3452–64.</span> [<a href="/pmc/articles/PMC6619533/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6619533</span></a>] [<a href="/pubmed/23426673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23426673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.lange.2017.1495">Lange LM, Tunc S, Tennstedt S, M&#x000fc;nchau A, Klein C, Assmann B, Lohmann K. A novel, in-frame KMT2B deletion in a patient with apparently isolated, generalized dystonia. <span><span class="ref-journal">Mov Disord. </span>2017;<span class="ref-vol">32</span>:1495–7.</span> [<a href="/pubmed/28921672" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28921672</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.mendhekar.2011.83">Mendhekar DN, Andrade C. Uneventful use of haloperidol and trihehexyphenidyl during three consecutive pregnancies. <span><span class="ref-journal">Arch Womens Ment Health. </span>2011;<span class="ref-vol">14</span>:83–4.</span> [<a href="/pubmed/21116668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21116668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.meyer.2017.223">Meyer E, Carss KJ, Rankin J, Nichols JME, Grozeva D, Joseph AP, Mencacci NE, Papandreou A, Ng J, Barral S, Ngoh A, Ben-Pazi H, Willemsen MA, Arkadir D, Barnicoat A, Bergman H, Bhate S, Boys A, Darin N, Foulds N, Gutowski N, Hills A, Houlden H, Hurst JA, Israel Z, Kaminska M, Limousin P, Lumsden D, McKee S, Misra S, Mohammed SS, Nakou V, Nicolai J, Nilsson M, Pall H, Peall KJ, Peters GB, Prabhakar P, Reuter MS, Rump P, Segel R, Sinnema M, Smith M, Turnpenny P, White SM, Wieczorek D, Wiethoff S, Wilson BT, Winter G, Wragg C, Pope S, Heales SJH, Morrogh D. UK10K Consortium, Deciphering Developmental Disorders Study, NIHR BioResource Rare Diseases Consortium, Pittman A, Carr LJ, Perez-Due&#x000f1;as B, Lin JP, Reis A, Gahl WA, Toro C, Bhatia KP, Wood NW, Kamsteeg EJ, Chong WK, Gissen P, Topf M, Dale RC, Chubb JR, Raymond FL, Kurian MA. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia. <span><span class="ref-journal">Nat Genet. </span>2017;<span class="ref-vol">49</span>:223–37.</span> [<a href="/pubmed/27992417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27992417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.muramoto.2010.397">Muramoto T, M&#x000fc;ller I, Thomas G, Melvin A, Chubb JR. Methylation of H3K4 is required for inheritance of active transcriptional states. <span><span class="ref-journal">Curr Biol. </span>2010;<span class="ref-vol">20</span>:397–406.</span> [<a href="/pubmed/20188556" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20188556</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.nageshwaran.2011">Nageshwaran S, Nageshwaran S, Edwards MJ, Morcos M. Management of DYT1 dystonia throughout pregnancy. BMJ Case Rep. 2011;2011. [<a href="/pmc/articles/PMC3176356/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3176356</span></a>] [<a href="/pubmed/22679185" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22679185</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.park.2017.155">Park HR, Lee JM, Park H, Shin CW, Kim HJ, Park HP, Kim DG, Jeon BS, Paek SH. Pregnancy and delivery in a generalized dystonia patient treated with internal globus pallidal deep brain stimulation: a case report. <span><span class="ref-journal">J Korean Med Sci. </span>2017;<span class="ref-vol">32</span>:155–9.</span> [<a href="/pmc/articles/PMC5143289/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5143289</span></a>] [<a href="/pubmed/27914146" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27914146</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.rilstone.2013.543">Rilstone JJ, Alkhater RA, Minassian BA. Brain dopamine-serotonin vesicular transport disease and its treatment. <span><span class="ref-journal">N Engl J Med. </span>2013;<span class="ref-vol">368</span>:543–50.</span> [<a href="/pubmed/23363473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23363473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.robottom.2011.340">Robottom BJ, Reich SG. Exposure to high dosage trihexyphenidyl during pregnancy for treatment of generalized dystonia: case report and literature review. <span><span class="ref-journal">Neurologist. </span>2011;<span class="ref-vol">17</span>:340–1.</span> [<a href="/pubmed/22045287" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22045287</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.scelzo.2015.191">Scelzo E, Mehrkens JH, B&#x000f6;tzel K, Krack P, Mendes A, Chabard&#x000e8;s S, Polosan M, Seigneuret E, Moro E, Fraix V. Deep brain stimulation during pregnancy and delivery: experience from a series of "DBS Babies". <span><span class="ref-journal">Front Neurol. </span>2015;<span class="ref-vol">6</span>:191.</span> [<a href="/pmc/articles/PMC4556026/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4556026</span></a>] [<a href="/pubmed/26388833" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26388833</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.serikawa.2011.72">Serikawa T, Shimohata T, Akashi M, Yokoseki A, Tsuchiya M, Hasegawa A, Haino K, Koike R, Takakuwa K, Tanaka K, Tanaka K, Nishizawa M. Successful twin pregnancy in a patient with parkin-associated autosomal recessive juvenile parkinsonism. <span><span class="ref-journal">BMC Neurol. </span>2011;<span class="ref-vol">11</span>:72.</span> [<a href="/pmc/articles/PMC3135525/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3135525</span></a>] [<a href="/pubmed/21682904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21682904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.shi.2007.1">Shi Y, Whetstine JR. Dynamic regulation of histone lysine methylation by demethylases. <span><span class="ref-journal">Mol Cell. </span>2007;<span class="ref-vol">25</span>:1–14.</span> [<a href="/pubmed/17218267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17218267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.shilatifard.2008.341">Shilatifard A. Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. <span><span class="ref-journal">Curr Opin Cell Biol. </span>2008;<span class="ref-vol">20</span>:341–8.</span> [<a href="/pmc/articles/PMC2504688/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2504688</span></a>] [<a href="/pubmed/18508253" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18508253</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.watanabe.2012.559">Watanabe T, Matsubara S. Good obstetric outcome in a patient with Segawa disease. <span><span class="ref-journal">Arq Neuropsiquiatr. </span>2012;<span class="ref-vol">70</span>:559–60.</span> [<a href="/pubmed/22836471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22836471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.watanabe.2009.562">Watanabe T, Matsubara S, Baba Y, Tanaka H, Suzuki T, Suzuki M. Successful management of pregnancy in a patient with Segawa disease: case report and literature review. <span><span class="ref-journal">J Obstet Gynaecol Res. </span>2009;<span class="ref-vol">35</span>:562–4.</span> [<a href="/pubmed/19527400" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19527400</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.zech.2016.1377">Zech M, Boesch S, Maier EM, Borggraefe I, Vill K, Laccone F, Pilshofer V, Ceballos-Baumann A, Alhaddad B, Berutti R, Poewe W, Haack TB, Haslinger B, Strom TM, Winkelmann J. Haploinsufficiency of KMT2B, encoding the lysine-specific histone methyltransferase 2B, results in early-onset generalized dystonia. <span><span class="ref-journal">Am J Hum Genet. </span>2016;<span class="ref-vol">99</span>:1377–87.</span> [<a href="/pmc/articles/PMC5142117/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5142117</span></a>] [<a href="/pubmed/27839873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27839873</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.zech.2017a.1087">Zech M, Jech R, Havr&#x000e1;nkov&#x000e1; P, Fe&#x0010d;&#x000ed;kov&#x000e1; A, Berutti R, Urgo&#x00161;&#x000ed;k D, Kemlink D, Strom TM, Roth J, R&#x0016f;&#x0017e;i&#x0010d;ka E, Winkelmann J. KMT2B rare missense variants in generalized dystonia. <span><span class="ref-journal">Mov Disord. </span>2017a;<span class="ref-vol">32</span>:1087–91.</span> [<a href="/pubmed/28520167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28520167</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.zech.2017b.195">Zech M, Jech R, Wagner M, Mantel T, Boesch S, Nocker M, Jochim A, Berutti R, Havr&#x000e1;nkov&#x000e1; P, Fe&#x0010d;&#x000ed;kov&#x000e1; A, Kemlink D, Roth J, Strom TM, Poewe W, R&#x0016f;&#x0017e;i&#x0010d;ka E, Haslinger B, Winkelmann J. Molecular diversity of combined and complex dystonia: insights from diagnostic exome sequencing. <span><span class="ref-journal">Neurogenetics. </span>2017b;<span class="ref-vol">18</span>:195–205.</span> [<a href="/pubmed/28849312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28849312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.zhou.2011.7">Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of mammalian genomes. <span><span class="ref-journal">Nat Rev Genet. </span>2011;<span class="ref-vol">12</span>:7–18.</span> [<a href="/pubmed/21116306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21116306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="kmt2b-dystonia.REF.ziman.2016.60">Ziman N, Coleman RR, Starr PA, Volz M, Marks WJ Jr, Walker HC, Guthrie SL, Ostrem JL. Pregnancy in a series of dystonia patients treated with deep brain stimulation: outcomes and management recommendations. <span><span class="ref-journal">Stereotact Funct Neurosurg. </span>2016;<span class="ref-vol">94</span>:60–5.</span> [<a href="/pubmed/26977859" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26977859</span></a>]</div></li></ul></div></div><div id="kmt2b-dystonia.Chapter_Notes"><h2 id="_kmt2b-dystonia_Chapter_Notes_">Chapter Notes</h2><div id="kmt2b-dystonia.Author_Notes"><h3>Author Notes</h3><p>Dr Lucia Abela<br />Developmental Neurosciences<br />UCL-Great Ormond Street Institute of Child Health, London</p><p>Dr Abela is a senior resident in pediatric neurology and currently a research fellow in Dr Kurian's research group with a special interest in childhood movement disorders.</p><p>Dr Manju Kurian<br />Developmental Neurosciences<br />UCL-Great Ormond Street Institute of Child Health, London</p><p>Dr Kurian is a pediatric neurologist and clinician-scientist with a clinical and research interest in childhood movement disorders.</p><p><a href="https://iris.ucl.ac.uk/iris/browse/profile?upi=MKURI59" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Dr Kurian's web page</a></p></div><div id="kmt2b-dystonia.Acknowledgments"><h3>Acknowledgments</h3><p>Dr Kurian is funded by an NIHR Research Professorship and the Wellcome Trust. Dr Abela is funded by a Swiss National Foundation Advanced Postdoc Mobility fellowship.</p></div><div id="kmt2b-dystonia.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>26 April 2018 (bp) Review posted live</div></li><li class="half_rhythm"><div>19 October 2017 (la/mak) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK493766</span><span class="label">PMID: <a href="/pubmed/29697234" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">29697234</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kcnt1-epilepsy/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/kabuki/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK493766&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK493766/?report=reader">PubReader</a></li><li><a href="/books/NBK493766/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK493766" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK493766" style="display:none" title="Cite this Page"><div class="bk_tt">Abela L, Kurian MA. KMT2B-Related Dystonia. 2018 Apr 26. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK493766/pdf/Bookshelf_NBK493766.pdf">PDF version of this page</a> (812K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#kmt2b-dystonia.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#kmt2b-dystonia.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#kmt2b-dystonia.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#kmt2b-dystonia.Genetically_Related_Allel" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#kmt2b-dystonia.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#kmt2b-dystonia.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#kmt2b-dystonia.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#kmt2b-dystonia.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#kmt2b-dystonia.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#kmt2b-dystonia.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#kmt2b-dystonia.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9757[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KMT2B</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4527174" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4527174" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4527174" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4527174" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30605297" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> DYT-GNAL</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> DYT-GNAL<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Deutschländer AB, Wszolek ZK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301587" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SGCE</i> Myoclonus-Dystonia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SGCE</i> Myoclonus-Dystonia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Raymond D, Saunders-Pullman R, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28211668" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Propeller Protein-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Propeller Protein-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Haack T, Hayflick SJ, Hogarth P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301681" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Furukawa Y. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=29697234" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=29697234" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0429cadde0891169a466e1">KMT2B-Related Dystonia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">KMT2B-Related Dystonia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:32:26-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B389FE041FAB100000000048F01AB&amp;ncbi_session=CE8B389FE0429C91_1167SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK493766%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK493766&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK493766/&amp;ncbi_pagename=KMT2B-Related Dystonia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B389FE0429C91_1167SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>